Passiglia F, Righi L, Bironzo P, Listi A, et al. Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer harboring HRR mutations: interim results of the UNITO-001 phase 2 prospective trial. Clin Cancer Res 2023 Dec 18. doi: 10.1158/1078-0432.CCR-23-2431.
PMID: 38109438